Financial reports
No filings
Current reports
No filings
Registration and prospectus
D/A
Indefinite amount in investment fund, sold $8.05 bn, 858 investors
8 Mar 24
D/A
Indefinite amount in investment fund, sold $7.80 bn, 858 investors
10 Mar 23
D/A
Indefinite amount in investment fund, sold $7.29B, 846 investors
11 Mar 22
D/A
Indefinite amount in investment fund, sold $7.21B, 845 investors
12 Mar 21
D/A
Indefinite amount in investment fund, sold $6.96B, 802 investors
13 Mar 20
D/A
Indefinite amount in investment fund, sold $6.88B, 769 investors
15 Mar 19
D/A
Indefinite amount in investment fund, sold $6.76B, 752 investors
16 Mar 18
D/A
Indefinite amount in investment fund, sold $6.63B, 737 investors
17 Mar 17
D/A
Indefinite amount in investment fund, sold $6.53B, 723 investors
18 Mar 16
D/A
Indefinite amount in investment fund, sold $6.36B, 707 investors
18 Mar 15
Proxies
DFAN14A
Additional proxy materials by non-management
15 May 23
DFAN14A
Additional proxy materials by non-management
11 May 23
DFAN14A
Additional proxy materials by non-management
8 May 23
DFAN14A
Additional proxy materials by non-management
8 May 23
DFAN14A
Additional proxy materials by non-management
3 May 23
DEFC14A
Proxy in contested solicitation
3 May 23
DFAN14A
Additional proxy materials by non-management
25 Apr 23
DFAN14A
Additional proxy materials by non-management
24 Apr 23
PRRN14A
Revised preliminary proxy statement filed by non-management
21 Apr 23
PREC14A
Preliminary proxy with contested solicitation
6 Apr 23
Other
No filings
Ownership
SC 13G/A
Forte Biosciences, Inc.
14 Feb 24
SC 13G/A
Revolution Medicines, Inc.
12 Feb 24
SC 13G/A
Beam Therapeutics Inc.
12 Feb 24
SC 13G/A
AGIOS PHARMACEUTICALS, INC.
8 Feb 24
SC 13G/A
Aramark
6 Feb 24
SC 13D/A
Cazoo Group Ltd
5 Feb 24
SC 13G/A
Swiftmerge Acquisition Corp.
5 Feb 24
SC 13G/A
Protagonist Therapeutics, Inc
2 Feb 24
SC 13G/A
Savara Inc
1 Feb 24
SC 13G/A
Berenson Acquisition Corp. I
30 Jan 24